Compugen, an Israeli cancer immunotherapy company that calls itself a pioneer in computational target discovery, has ...

The Russian authorities are preparing for a further reduction of the share of imported drugs in the domestic public ...

Privately-held Remedy Plan Therapeutics, a US pharma company developing novel, hyperbolic NAMPT inhibitors, has raised more ...

Belgian clinical-stage biotech iTeos Therapeutics (Nasdaq: ITOS) saw its shar leap18.6% to $8.20 today, despite posting ...

Swiss pharma giant Roche (ROG: SIX), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit ...

Swedish biotech Hansa Biopharma (Nasdaq Stockholm: HNSA) has appointed Maria Törnsén as chief operating officer and president ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Adzynma (apadamtase alfa/cinaxadamtase alfa; ...

They are the two drugs of the moment, the weight loss products promising a miraculous solution to obesity and—in data ...

Denmark’s Novo Nordisk has presented data at the European Congress of Obesity (ECO) showing that Wegovy (semaglutide ...

India has declined the UK's request to include a 'data exclusivity' clause in the proposed Free Trade Agreement (FTA), as ...

Swedish contract development and manufacturing firm Recipharm and France-based regulatory specialist ProductLife Group (PLG) ...

Hungary’s largest drugmaker Gedeon Richter (RICHT: HB) has announced its financial results for the first quarter of 2025, ...